Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Asset disposition
Quarterly results
Director departure
Appointed director
CC transcript
Credit agrmnt [a]
|
|
ABBOTT LABORATORIES (ABT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Stratton John G (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 379 options to buy
@ $96.85, valued at
$36.7k
|
|
| 10/03/2023 |
4
| Roman Michael F (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 363 options to buy
@ $96.85, valued at
$35.2k
|
|
| 10/03/2023 |
4
| Gonzalez Patricia Paola (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 340 options to buy
@ $96.85, valued at
$32.9k
|
|
| 10/03/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 81 options to buy
@ $96.85, valued at
$7.8k
|
|
| 08/10/2023 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 4,741 shares
@ $105, valued at
$497.8k
Sold 244 shares
@ $105.43, valued at
$25.7k
Sold 15 shares
@ $107.42, valued at
$1.6k
Sold 5,112 shares
@ $105, valued at
$536.8k
Sold 272 shares
@ $105.43, valued at
$28.7k
Sold 16 shares
@ $107.42, valued at
$1.7k
Exercised 5,000 options to buy
@ $38.4, valued at
$192k
|
|
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
4
| Stratton John G (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 325 options to buy
@ $109.02, valued at
$35.4k
|
|
| 07/05/2023 |
4
| Roman Michael F (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 316 options to buy
@ $109.02, valued at
$34.5k
|
|
| 07/05/2023 |
4
| Gonzalez Patricia Paola (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 302 options to buy
@ $109.02, valued at
$32.9k
|
|
| 07/05/2023 |
4
| Morrone Louis H. (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,815 shares
@ $0
Paid exercise price by delivering 556 shares
@ $109.02, valued at
$60.6k
Granted 7,100 options to buy
@ $108.52, valued at
$770.5k
|
|
| 07/05/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 72 options to buy
@ $109.02, valued at
$7.8k
|
|
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/09/2023 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
4
| Wainer Andrea F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 8,226 shares
@ $110.5607, valued at
$909.5k
Exercised 8,226 options to buy
@ $47, valued at
$386.6k
|
|
| 05/03/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 05/02/2023 |
4
| Stratton John G (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
| 05/02/2023 |
4
| STARKS DANIEL J (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0
Sold 46,548 shares
@ $110.97, valued at
$5.2M
Sold 3,452 shares
@ $111.75, valued at
$385.8k
Granted 8,136 options to buy
@ $110.12, valued at
$895.9k
|
|
| 05/02/2023 |
4
| Roman Michael F (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
| 05/02/2023 |
4
| O'Grady Michael (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0
Granted 4,576 options to buy
@ $110.12, valued at
$503.9k
|
|
| 05/02/2023 |
4
| McKinstry Nancy (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0
Granted 9,861 options to buy
@ $110.12, valued at
$1.1M
|
|
| 05/02/2023 |
4
| McDew Darren W (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
| 05/02/2023 |
4
| Kumbier Michelle (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
| 05/02/2023 |
4
| Gonzalez Patricia Paola (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
| 05/02/2023 |
4
| Blount Sally E. (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
| 05/02/2023 |
4
| Babineaux-Fontenot Claire (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
| 05/02/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 1,816 shares
@ $0 |
|
|
|
|